Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review

Autophagy has been of novel interest since it was first demonstrated to have effect in Burkitt’s lymphoma. Since that time, the autophagy agents chloroquine and hydroxychloroquine have become the only FDA (Food and Drug Administration)-approved autophagy inhibitors. While not approved for cancer the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohsen, Samiha, Sobash, Philip T., Algwaiz, Ghada Fahad, Nasef, Noor, Al-Zeidaneen, Safaa Abed, Karim, Nagla Abdel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946974/
https://www.ncbi.nlm.nih.gov/pubmed/35323341
http://dx.doi.org/10.3390/curroncol29030141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946974/
https://www.ncbi.nlm.nih.gov/pubmed/35323341
http://dx.doi.org/10.3390/curroncol29030141

Ejemplares similares